United Kingdom
Medical device market intelligence for United Kingdom. Regulatory changes, competitor moves, and procurement trends.
Recent signals
The Vascutek Fenestrated Anaconda™ system is under a non-interventional study for abdominal aortic aneurysm treatment.
The study examines the safety and efficacy of the Pipeline Embolization Device with Vantage Technology for unruptured brain aneurysms.
A study will assess the NucleoCapture device's safety and performance in reducing cfDNA/NETs in pancreatitis patients.
The NMPA updated the registration for the Emit® 2000 Mycophenolic Acid Assay, a diagnostic reagent kit.
Becton Dickinson UK Ltd recalls ChloraPrep applicators due to potential sterility breach in packaging.
The UK MedTech community will gather in Birmingham for the Med-Tech Expo 2026, showcasing industry highlights.
The MHRA provides updated safety advice for medical device users in May 2026.
The 'Melody' paracentesis device aims to improve ascites drainage efficiency compared to standard methods.
The completed study evaluated the Creavo Vitalscan Magnetocardiograph in post-myocardial infarction patients.
Med-Tech Expo offers free registration for access to three co-located manufacturing events in Birmingham next week.
Ewa Truchanowicz discusses communication gaps in healthcare innovation at Med-Tech Expo 2026.
The Cytosponge™ device was tested for post-chemoradiation surveillance in oesophageal cancer patients in a completed study.
Signature Orthopaedics Pty Limited is registered with the FDA under code JWH, listing 2 products.
A prototype Valsalva Assist Device has completed testing in healthy volunteers to evaluate physiological responses.
A new lateral flow device test aims to quickly diagnose Aspergillosis in children at risk of invasive fungal disease.
A completed study suggests that a medical device enhancing blood flow may expedite healing in diabetic foot ulcers.
A new implantable device using micro-LEDs could enhance bladder cancer treatment effectiveness.
The UK plans tougher regulations on health self-testing kits due to safety concerns and misleading claims.
Resmed launched AirConnect Dx in the UK to enhance NHS sleep services' diagnostic capacity for OSA.
M&A and divestitures are reshaping MedTech strategies, emphasizing market access for sustained growth and valuation.